Dutch health technology company Philips has lowered its sales growth forecast for 2026, citing ongoing economic pressures and rising costs linked to U.S. tariffs.
Shares of Dutch health technology company Philips (PHG.AS) fell more than 7% on Thursday, marking their biggest decline in nearly 10 months, following comments from CEO Roy Jakobs at Citi’s Global Healthcare Conference.
10 Feb 2026-10:25
04 Dec 2025-14:14
